Clinical Imaging Guidelines Part 4: Challenges in Identifying,Engaging and Collaborating With Stakeholders |
| |
| Institution: | 1. Department of Radiology, Wake Forest University, North Carolina;2. Department of Diagnostic Radiology, Oulu University Hospital, Oulu, Finland;3. Harvard Medical School & Massachusetts General Hospital, Boston, Massachusetts;4. Radiation Protection of Patients Unit, International Atomic Energy Agency, Vienna International Center, Vienna, Austria;5. Radiation Programme, Department of Public Health, Environmental and Social Determinants of Health (PHE) Cluster of Family, Women''s and Children''s Health (FWC) World Health Organization (WHO), Geneva, Switzerland;6. Standards of Practice and Accreditation, RANZCR, Sydney, Australia;7. Korean Society of Radiology, Asan Medical Center, Seoul, Korea;8. Department of Radiology, Massachusetts General Hospital, and Department of Radiology, Harvard Medical School, Boston, Massachusetts;9. Medical Exposure Regulatory Infrastructure Team CRCE, Public Health England Chilton, Didcot Oxfordshire, United Kingdom;1. Rush University, Chicago, Illinois;2. Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri;3. Department of Radiology, University of Chicago, Chicago, Illinois;4. US Department of Veterans Affairs, Washington, District of Columbia;5. Department of Radiology, Mount Sinai School of Medicine, New York, New York;6. Department of Radiology, University of Michigan Hospitals, Ann Arbor, Michigan;7. Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California;8. Elucid Bioimaging Inc, Wenham, Massachusetts;9. Department of Radiology, Duke University, Durham, North Carolina;1. Houston VA Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas;2. Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA;3. Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA;4. Division of Radiology Informatics, Department of Radiology, University of Chicago Medical Center, Chicago, IL;1. Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts;2. Harvard Medical School, Boston, Massachusetts;3. Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts;4. Harvard School of Public Health, Cambridge, Massachusetts;1. Baylor College of Medicine, Houston, Texas;2. American Board of Medical Specialties, Tucson, Arizona |
| |
| Abstract: | The effective development and use of clinical imaging guidelines requires an understanding of who the stakeholders are, what their interests in the process are, and what roles they should play. If the appropriate stakeholders are not engaged in the right roles, it is unlikely that clinical imaging guidelines will be successfully developed, relied on, and actually used. Some stakeholders are obvious: for the development of clinical imaging guidelines, both imagers and those who request examinations, such as general practitioners, internists, and medical specialists, must be involved. To gain acceptance, other relevant groups are stakeholders, including medical societies, other health care professionals, insurers, health IT experts and vendors, and patients. The role of stakeholders must be dictated by their specific interest. For some, involvement in the creation of guidelines is the right role. For others, such as regulators or insurers, reviews or invitations to comment are required, and for others, such as medical educators, it is probably sufficient to provide information and create awareness. Only through a careful consideration of who the stakeholders are and what are their interests are the successful development, acceptance, and use of clinical imaging guidelines likely to occur. Future efforts must focus on collaboration, particularly among groups that create clinical imaging guidelines and those that can support their use, and on regulatory roles and mandates. |
| |
| Keywords: | Imaging stakeholders clinical imaging guidelines guideline development roles |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
